SCHEMBL9955616

SCHEMBL9955616

CC(C)(CC(O)(CC=O)c1ccccc1)O[Si](C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
KCNN4 O15554 1/20 0.33
HIF1A Q16665 1/20 0.33
ALDH1A1 P00352 4/20 0.32
ALOX15 P16050 1/20 0.32
BLM P54132 1/20 0.31
KDM4E B2RXH2 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
CYP2D6 P10635 1/20 0.31
GAA P10253 1/20 0.30
KMT2A Q03164 3/20 0.30
TSHR P16473 1/20 0.30
MAPT P10636 1/20 0.30
ATM Q13315 1/20 0.30
LMNA P02545 1/20 0.30
HTT P42858 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9955607 1.00 CYP2C19 (0.34) CYP2C19CYP1A2CYP2C9KCNN4HIF1A
SCHEMBL9954628 0.86 ALDH1A1 (0.40) CYP2C19CYP1A2CYP2C9HIF1AALDH1A1
SCHEMBL15674545 0.86 ALDH1A1 (0.40) CYP2C19CYP1A2CYP2C9HIF1AALDH1A1
SCHEMBL15697479 0.80 CYP2C19 (0.41) CYP2C19CYP1A2CYP2C9KCNN4HIF1A
SCHEMBL15697478 0.80 CYP2C19 (0.41) CYP2C19CYP1A2CYP2C9KCNN4HIF1A
SCHEMBL117719 0.72 KCNN4 (0.42) CYP2C19CYP1A2CYP2C9KCNN4HIF1A
SCHEMBL11648782 0.69 CYP2C19 (0.46) CYP2C19CYP1A2CYP2C9HIF1AALDH1A1
SCHEMBL10036198 0.68 MAPK1 (0.34) CYP2C19HIF1AALDH1A1ALOX15MAPK1
SCHEMBL14043521 0.68 POLB (0.48) CYP2C19CYP1A2CYP2C9KCNN4ALDH1A1
SCHEMBL14292070 0.66 MAPK1 (0.46) CYP2C19KCNN4HIF1AALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8916701-B2 Methods of making diastereomeric organic compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-12-23 US disclosed
US-8916701-B2 Methods of making diastereomeric organic compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-12-23 US disclosed
EP-2655349-B1 METHODS OF MAKING DIASTEREOMERIC ORGANIC COMPOUNDS BOEHRINGER INGELHEIM INT (DE) 2014-10-15 EP disclosed
EP-2655349-B1 METHODS OF MAKING DIASTEREOMERIC ORGANIC COMPOUNDS BOEHRINGER INGELHEIM INT (DE) 2014-10-15 EP disclosed
US-20140135493-A1 METHODS OF MAKING DIASTEREOMERIC ORGANIC COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-05-15 US disclosed
US-20140135493-A1 METHODS OF MAKING DIASTEREOMERIC ORGANIC COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-05-15 US disclosed
EP-2655349-A1 METHODS OF MAKING DIASTEREOMERIC ORGANIC COMPOUNDS Boehringer Ingelheim International GmbH (DE) 2013-10-30 EP disclosed
WO-2012087720-A1 METHODS OF MAKING DIASTEREOMERIC ORGANIC COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-28 WO disclosed
WO-2012087720-A1 METHODS OF MAKING DIASTEREOMERIC ORGANIC COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140135493-A1 METHODS OF MAKING DIASTEREOMERIC ORGANIC COMPOUNDS HSD11B1, HSD11B2, HSD17B1 CYP2C19 67/4885CYP1A2 58/4885CYP2C9 72/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.